Results 41 to 50 of about 223,805 (315)

Non-neoplastic conditions mimicking peritoneal carcinomatosis at CT imaging.

British Journal of Radiology, 2020
The generalappearance of peritoneal carcinomatosis at abdominal CT and other cross-sectional imaging modalities consists of varying amounts of peritoneal-based soft tissue implants (mass-forming or infiltrative), peritoneal fluid, and occasionally ...
Mohab M. Elmohr, K. Elsayes, P. Pickhardt   +2 more
semanticscholar   +1 more source

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases

Trials, 2010
Background The standard of care for colorectal peritoneal carcinomatosis is evolving from chemotherapy to cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with disease limited to the peritoneum.
Steinberg Seth M, Kemp Clinton D, Davis Jeremy L, Ripley Robert T, Toomey Mary, Avital Itzhak   +5 more
doaj   +1 more source

Identifying the source of peritoneal carcinomatosis by molecular biological method (a clinical case) [PDF]

РМЖ. Мать и дитя, 2023
K.R. Ishmuratova1,2 1Bashkir State Medical University, Ufa, Russian Federation 2Republican Clinical Oncological Dispensary, Ufa, Russian Federation In recent decades, multiple biological markers have been discovered which demonstrate a high ...
K.R. Ishmuratova
doaj  

Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis : mission possible? [PDF]

, 2017
A
Ceelen, Wim, Dakwar, George, De Smedt, Stefaan, Remaut, Katrien, Shariati, Molood, Willaert, Wouter   +5 more
core   +2 more sources

Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model [PDF]

, 2015
Cytoreductive surgery combined with intraperitoneal chemotherapy (IPC) is currently the standard treatment for selected patients with peritoneal carcinomatosis of colorectal cancer.
Ceelen, Wim, De Wever, Olivier, Descamps, Benedicte, Gremonprez, Félix, Izmer, Andrei, Vanhaecke, Frank, Vanhove, Christian   +6 more
core   +7 more sources

Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy

Case Reports in Medicine, 2013
Hepatoid carcinoma of the ovary (HCO) was first reported in 1987 in 5 cases of malignant ovarian tumors which were similar to hepatocarcinoma in the histological analysis. We report the first case in the literature of a patient diagnosed with HCO treated
Pedro Antonio Cascales Campos, Jose Gil Martinez, Amparo Torroba, Francisco Machado, Pascual Parrila Paricio   +4 more
doaj   +1 more source

Prognostic factors influencing infectious complications after cytoreductive surgery and HIPEC. Results from a tertiary referral center [PDF]

, 2019
Background. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application.
Carbonari, Ludovica, Cardi, Maurizio, D'Agostino, Claudia, Fonsi, Giovanni Battista, Francesco Di Marzo,, Francesco, Lefoche, LA TORRE, Giuseppe, Sammartino, Paolo, Sibio, Simone   +8 more
core   +1 more source

Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis

Journal for ImmunoTherapy of Cancer, 2020
Background Peritoneal carcinomatosis is a hallmark of advanced peritoneal tumor progression, particularly for tubal/ovarian high-grade serous carcinomas (HGSCs).
Chien-Fu Hung, Ssu-Hsueh Tseng, Sung-Taek Park, Brandon Lam, Ya-Chea Tsai, Max A Cheng, Emily Farmer, Deyin Xing   +7 more
doaj   +1 more source

Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial [PDF]

, 2011
Background: Peritoneal carcinomatosis (PC) is common in gastrointestinal (GI) cancer and there is no effective standard treatment. We investigated the tolerability and maximum tolerated dose (MTD) of the trifunctional antibody catumaxomab in patients ...
Grützner, Klaus-Uwe, Heiss, Markus M., Hennig, Michael, Jauch, Karl-Walter, Jäger, Michael, Lindhofer, Horst, Lordick, Florian, Peschel, Christian, Rüttinger, Dominik, Schemanski, Oliver C., Ströhlein, Michael A.   +10 more
core   +1 more source

Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis

The Korean Journal of Gastroenterology, 2018
Background/Aims: Diagnostic tests for carcinoembryonic antigen (CEA) in ascites have been performed in various malignant cases, but there is only few data on the applicability of CEA for colorectal cancer (CRC) patients with peritoneal carcinomatosis. We
Sung Eun Song, Paul Choi, Jae Hyun Kim, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park   +7 more
doaj   +1 more source